Evidence map›Paper›PMID 33510701›Full record

ArticleFrontiers in neurology2020

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort.

Helen Cross, Farahna Sabiq, Nathalie Ackermans, Andrew Mattar, Shelly Au, Mark Woodhall, Bo Sun, Virginia Devonshire, Robert Carruthers, Ana Luiza Sayao and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Helen CrossUBC MS/NMO Clinic, University of British Columbia, Vancouver, BC, Canada.
Farahna SabiqUBC MS/NMO Clinic, University of British Columbia, Vancouver, BC, Canada.
Nathalie AckermansDepartment of Neurology, Catholic University of Louvain, Louvain-la-Neuve, Belgium.
Andrew MattarUBC MS/NMO Clinic, University of British Columbia, Vancouver, BC, Canada.
Shelly AuUBC MS/NMO Clinic, University of British Columbia, Vancouver, BC, Canada.
Mark WoodhallAutoimmune Neurology Diagnostic Laboratory, University of Oxford, Oxford, United Kingdom.
Bo SunAutoimmune Neurology Diagnostic Laboratory, University of Oxford, Oxford, United Kingdom.
Virginia DevonshireUBC MS/NMO Clinic, University of British Columbia, Vancouver, BC, Canada.
Robert CarruthersUBC MS/NMO Clinic, University of British Columbia, Vancouver, BC, Canada.
Ana Luiza SayaoUBC MS/NMO Clinic, University of British Columbia, Vancouver, BC, Canada.
Virender BhanUBC MS/NMO Clinic, University of British Columbia, Vancouver, BC, Canada.
Alice SchabasUBC MS/NMO Clinic, University of British Columbia, Vancouver, BC, Canada.
Jillian ChanUBC MS/NMO Clinic, University of British Columbia, Vancouver, BC, Canada.
Marvin FritzlerMitogenDx, University of Calgary, Calgary, AB, Canada.
Patrick WatersAutoimmune Neurology Diagnostic Laboratory, University of Oxford, Oxford, United Kingdom.
Anthony TraboulseeUBC MS/NMO Clinic, University of British Columbia, Vancouver, BC, Canada.
University of British Columbia Hospital · CAUniversity of Oxford · GBUCLouvain · BEUniversity of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

aquaporin 4 antibodiesdemyelinationmultiple sclerosis (MS)myelin oligodendrocyte glycoprotein (MOG) antibodiesneuroinflammationneuromyelitis optica

Identifiers

PMID33510701
PMCPMC7835710
OpenAlexW3118540877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.